In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including: Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedules Available pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulations Current and potential models for adminis...
Aug 12, 2025•25 min•Ep. 23
In this episode, hear Allison Butts, PharmD, BCOP and Danielle Roman, PharmD, BCOP, share their insights on the best practices for incorporating antibody–drug conjugates (ADCs) into clinical practice including: An overview of ADC structure and mechanism of action A topline review of data supporting the current FDA-approved indications for ADCs targeting HER2 and TROP-2 across multiple tumor types An in-depth look at common and serious adverse events with each approved ADC along with an overview ...
Jun 27, 2025•34 min•Ep. 22
In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection) Cough as the most significant symptom and burden Imaging bronchiectasis with classic and inflammatory findings Differentiating the causes of NCFBE to inform patient care Presenters Brett M....
Jun 18, 2025•24 min•Ep. 21
Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss how to manage the multidisciplinary care of patients with systemic mastocytosis (SM) from both the allergy/immunology and pharmacy perspective, including: Strategies to better identify patients presenting with features of SM to facilitate timely diagnosis Current guideline-recommended treatment approaches Emerging data on new targeted agents for SM Pharmacist-led strategies to help patients achieve better...
May 16, 2025•31 min•Ep. 20
In this podcast episode, Allison Butts, PharmD, BCOP, reviews how pharmacists can help in providing comprehensive patient-centric care for patients with HR+/HER2- MBC and preexisting comorbid conditions, including: Common comorbidities and complexities in managing patients with HR+/HER2- MBC Treatment landscape for patients with HR+/HER2- MBC Real-world studies in women with HR+/HER2- MBC Mitigation and management of drug interactions and multidisciplinary team coordination treatment selection P...
Apr 29, 2025•17 min•Ep. 19
In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about: How and when to monitor and treat mild vs severe immune-related toxicities The art of balancing and tapering low-dose and high-dose corticosteroids Differentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal manage...
Jan 10, 2025•30 min•Ep. 18
In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care Provide HBV management resources to support PCPs who are doing screening Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV Presenters: Su Wang, MD, MPH, FACP Medical Director Center for Asian Health and Viral He...
Apr 26, 2024•19 min•Ep. 17
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, D...
Mar 26, 2024•21 min•Ep. 16
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV screening Pr...
Dec 22, 2023•28 min•Ep. 15
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including: Burden of CRE infections in the United States Mechanisms of resistance Changing epidemiology Use of rapid diagnostic tests IDSA guidance recommendations, including supporting data Approach to designing treatment regimens, including weighing patient- and infection-related factors Faculty: Julie Ann Justo, PharmD, MS, FIDSA, BCPS Clinical Pharmacist L...
Dec 07, 2023•16 min•Ep. 14
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman provide practical strategies for implementing RSV vaccination into practice, including: Educating older adults on RSV vaccines Providing effective, evidence-based recommendations Shared decision-making Identifying and addressing vaccine hesitancy Proactive strategies in vaccinating for RSV Predicting and overcoming barriers to RSV vaccination Presenters: Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP Clin...
Nov 27, 2023•20 min•Ep. 12
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including: Role of basic public health precautions Available and emerging vaccines Mechanisms of action, therapeutic targets, and pharmacology Efficacy and safety data FDA approval status and ACIP recommendations Presenters: Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP Clinical Professor Ernest Mario School of Pharmacy...
Nov 21, 2023•17 min•Ep. 13
In this accredited podcast episode, Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, discusses the most important things for pharmacists across all settings to know about RSV infections in patients 60 years of age or older, including: Incidence and prevalence of RSV in older adults, including hospitalization, mortality, epidemiology Seasonality Clinical manifestations Risk factors for severe outcomes Vulnerable groups and comorbidities Presenter: Mary Barna Bridgeman, PharmD, BCPS, B...
Nov 21, 2023•13 min•Ep. 11
In this episode, Sarah Hayward, PharmD, BCOP, and Amy Ly Indorf, PharmD, BCOP, discuss their experiences providing care for patients with advanced ovarian cancer, with topics including: PARP inhibitors as frontline maintenance therapy Patient education and counseling on PARP inhibitors Helping patients access newer therapies Experiences with mirvetuximab soravtansine Patient education and counseling on mirvetuximab soravtansine Treatment modalities on the horizon Presenters : Sarah Hayward, Phar...
Jun 28, 2023•15 min•Ep. 10
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including: Current COVID-19 landscape Rapid antigen tests and PCR tests Risk stratification of patients who have a positive SARS-CoV-2 test Antiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir) Long COVID Presenters: Renslow Sherer, MD Director, International HIV Training Center Professor of Medicine Section of ...
May 03, 2023•1 hr 15 min•Ep. 9
In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; ...
Nov 04, 2022•23 min•Ep. 8
In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including: Overview of chronic kidney disease Guideline recommendations Evidence for finerenone Role of the pharmacist Presenter: Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Endocrine Clinical Pharmacy Specialist CGM and Remot...
May 17, 2022•29 min•Ep. 7
This podcast is the third in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, pharmacist Kathleen A. Lusk, PharmD, BCPS, BCCP, provides an overview of health disparities, patient engagement, and collaborative team-based care to optimize outcomes for patients with NVAF. Dr Lusk reviews best practices in using the principles of motivational interviewing to employ shared decision-making and models these strategies wi...
Apr 26, 2022•31 min•Ep. 6
This podcast is the second in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, cardiology pharmacist Stephanie Dwyer Kaluzna, PharmD, BCCP, reviews key literature and guideline recommendations for stroke prevention in patients with NVAF. Dr Dwyer Kaluzna discusses the most recent evidence for prescribing, dosing, and monitoring direct oral anticoagulants (DOACs); using the risk-screening tools HAS-BLED and CHA2DS2...
Apr 25, 2022•28 min•Ep. 5
This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings. Presenters: Kathleen A. Lusk, PharmD, BCPS, BCCP Associate Professor and Vic...
Apr 25, 2022•30 min•Ep. 4
In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care. Presenters: Megan Adelman, PharmD, BCPS, BCGP, CDCES Family Medicine Clinical Specialist Center for Family Medicine...
Apr 22, 2022•1 hr 21 min•Ep. 3
Faculty Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Critical Care Pharmacy Specialist, Department of Pharmacy University of Colorado Hospital Aurora, Colorado Charles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCP Adjunct Associate Professor, Pharmacy University of New Mexico Health Sciences Center Albuquerque, New Mexico Content based on a CE activity supported by an educationa...
Jan 07, 2022•43 min•Ep. 2
1:08 - Take-home thoughts for R/R MM 3:47 - Summary of BCMA-targeted CAR T-cell therapy; Use of novel agents for R/R MM 6:47 - Information on melphalan flufenamide; Combination approaches with selinexor in clinical practice 9:59 - Cost considerations for treatment options in R/R MM 12:25 - Administration considerations for subcutaneous daratumumab and venetoclax in R/R MM Faculty Kathryn Maples, PharmD, BCOP Clinical Pharmacy Specialist, Multiple Myeloma Winship Cancer Institute, Emory Healthcar...
Sep 17, 2021•16 min•Ep. 1
